ELIAS Animal Health CEO, Tammie Wahaus, returns to the Dog Cancer Answers podcast to talk about ECI® as an alternative treatment to chemotherapy for canine osteosarcoma. Earlier this year the USDA determined that ECI® has demonstrated a reasonable expectation of efficacy, a major milestone in the product licensure pathway. Listen to the episode below to find out what’s next for ECI®, or read the full transcript at Dog Cancer Answers online.

Listen to more episodes of the Dog Cancer Answers podcast here.